Tax issues on stake sales and investment into managers: structuring, pitfalls and steps to take now
Supporting Private Capital Managers
Tailored solutions for the private capital industry.
Spotlight case study
/Passle/MediaLibrary/Images/2026-01-09-17-39-29-590-69613d511e42b4e613742f0c.jpg)
3 minute read
The latest contribution to this public discussion comes from the Institutional Limited Partners Association (ILPA), the influential lobbying body that seeks to advance LPs' interests. At the end of July 2024, ILPA issued guidance:
i. addressing the use of NAV financing in private equity strategies (the guidance expressly does not address its use in other strategies, such as private credit); and
ii. suggesting means for improved transparency and dialogue between LPs and those sponsors (GPs) looking to use NAV financing.
The guidance makes six key recommendations.
The recommendations relating to conflicts of interest and transparency are not surprising. They reflect what we see in the market already: GPs tend to be happy to discuss prospective NAV financings with LPs and/or LPACs. Similarly, as NAV financing continues to be a trending topic in the fund finance sector, LPs are increasingly alive to their use in private equity strategies and are eager to understand the associated risks and impacts as part of their investment diligence processes. As the ILPA guidance itself notes, some larger LPs are themselves keen to participate in NAV financing arrangements for the funds in which they have a primary investment.
The recommendations dealing with the interpretation of LPAs are perhaps more notable. It remains relatively rare for private equity fund LPAs to give GPs an express power to enter into NAV financings; instead, it is common for LPAs to:
In our experience, most GPs currently fundraising are resisting requests that any future NAV financings be subject to LP or LPAC consent. It will be interesting to see though how this point develops, and whether NAV finance providers start to push for LPAs to address NAV financings explicitly.
As with other ILPA guidance, it is worth noting that it is not intended to be universally appropriate or applicable in every instance. GPs should nevertheless be aware of the guidance and the likelihood that LPs will refer to it in NAV financing-related discussions and general due diligence processes.
Stay up to date with our latest insights, events and updates – direct to your inbox.
Browse our people by name, team or area of focus to find the expert that you need.